An observational study comparing effectiveness of Tocilizumab monotherapy versus tumor necrosis factor inhibitors in combination with Methotrexate in patients with Rheumatoid arthritis

Trial Profile

An observational study comparing effectiveness of Tocilizumab monotherapy versus tumor necrosis factor inhibitors in combination with Methotrexate in patients with Rheumatoid arthritis

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Jun 2017

At a glance

  • Drugs Tocilizumab (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Jun 2017 Results presented at the 18th Annual Congress of the European League Against Rheumatism.
    • 06 Feb 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top